The role of reduced growth rate in the development of drug resistance of HOB1 lymphoma cells to vincristine
- 30 September 1993
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 73 (2-3) , 105-111
- https://doi.org/10.1016/0304-3835(93)90251-4
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Multidrug resistant HOB1 lymphoma cells express P-glycoprotein that does not play the major role in the development of drug resistance to adriamycinBiochemical and Biophysical Research Communications, 1992
- Tumor suppressor genesCell, 1991
- The retinoblastoma protein is phosphorylated during specific phases of the cell cycleCell, 1989
- THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCEAnnual Review of Biochemistry, 1989
- Altered molecular properties of tubulin in a multidrug‐resistant variant of Chinese hamster cells selected for resistance to vinca alkaloidsJournal of Cellular Physiology, 1988
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- A technique for radiolabeling DNA restriction endonuclease fragments to high specific activityAnalytical Biochemistry, 1983
- Increased synthesis of a low molecular weight protein in vincristine-resistant cellsBiochemical and Biophysical Research Communications, 1981